Martin’s biotech fund to inject €39m into US drug company
Malin, the Irish biotech investment fund backed by former Elan boss Kelly Martin, will pump €39 million into an American drug company.
Malin, which intends to list on the Irish stock exchange later this month, has agreed to pay $18 million (€16.5 million) for an initial 41 per cent in Serenus Biotherapeutics. Depending on how Serenus performs, Malin will raise its shareholding in the company to 76 per cent for an additional $25 million.
Martin will become chairman of Serenus as part of the investment. Serenus is developing treatment for chronic and infectious diseases and ...
